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Nucleotidelack of any structural features that characterize membrane proteins, cytosolic
nucleoside-diphosphate kinases (NDPKs) have been found repeatedly to associate with membranes. In some
instances the recruitment of cytosolic NDPKs to membranes was attributed to interactions with peripheral or
integral membrane proteins, but in many cases the mechanism underlying the association of NDPKs with
membranes remained unknown. We show here that cytosolic NDPKs bind directly to membrane lipids in a
dynamic process that is controlled by its substrates, nucleoside tri- and diphosphates, and can be fully
reconstituted with chemically deﬁned, protein-free phospholipids and recombinant NDPK, or with puriﬁed
NDPK. Our results uncover a novel mechanism for the reversible targeting of soluble NDPKs to membranes,
where they may act as a reservoir of high energy phosphate, supporting the operation of membrane-based
processes that utilize nucleotides other than ATP, such as intracellular trafﬁc and phospholipid biosynthesis.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionNucleoside-diphosphate kinases (NDPKs) play a central role in a
broad rangeof cellular functions, includingnucleic acid synthesis, lipid,
and carbohydrate metabolism, through their ability to phosphorylate
nucleoside diphosphates utilizing the terminal phosphate of ATP [1,2].
These enzymes show broad base speciﬁcity, but display a preference
for adenine and guanine nucleotides. The phosphate transfer requires
Mg2+ and follows ping-pong kinetics [3], taking place via a phospho-
histidine intermediate. The reaction occurs in two steps,
E þ N1TP⇌E  N1TP⇌E∼P þ N1DP ðaÞ
E∼P þ N2DP⇌E∼P  N2DP⇌E þ N2TP ðbÞ
which when combined give the overall reaction sequence:
N1TP þ N2DP↔N1DPþ N2TP: ð1Þ
The most ubiquitous members of this family of proteins, NDPK A
and B (the products of the nm23-1 and -2 genes), are hexamers of two
highly (88%) homologous polypeptides of ∼20 kDa [4], with similar
kinetic parameters [5]. NDPK A and B are abundant proteins: their
estimated cytosolic concentration ranges from 1 to 10 μM. While
human NDPK A and B differ markedly in isoelectric point (theoretical
pI values are 5.8 and 8.5 for A and B, respectively), their murinel rights reserved.equivalents have pIs around 7. The three-dimensional structures for
human NDPK A and B are very similar [6,7], and the monomers of the
two proteins can associate, forming hetero-hexamers [4].
NDPK A and B have all the characteristics of cytosolic proteins, with
no exposed hydrophobic segments or membrane-binding motifs. Yet,
puriﬁcation and characterization of NDPK from rat liver plasma
membranes reveal that it is identical to the soluble protein [8]. Indeed,
in many instances cytosolic NDPKs associate with membranes of a
wide variety of intracellular compartments. At the plasma membrane
NDPKs inﬂuence the function of ion channels [9], receptor activation
and desensitization by agonists [10], activation of phagocyte NADPH
oxidase [11], dynamin-mediated endocytosis [12–14] and integrin-
mediated adhesion [15]. Soluble NDPKs also localize to endosomes
[14], membranes from the endoplasmic reticulum [16–19], the Golgi
and vesicles budding from the trans-Golgi [16], as well as phagosomes
[20]. In some cases the recruitment of cytosolic NDPKs to membranes
was ascribed to interactions with peripheral or integral membrane
proteins such as G proteins [21–23], integrin cytoplasmic domain
associated protein 1-α [15], the SET complex [17] and the potassium
channel KCa3.1 [9]. Overexpression of cytosolic NDPKs revealed novel
associations with the GTP-bound form of ARF6 [13], the thromboxane
A2 β receptor [10] and the von-Hippel Lindau protein [14], and these
binding partners were proposed to anchor NDPK to membranes.
Recently, NDPKs A and Bwere found to associate directly with puriﬁed
phospholipids [19,24].
Intracellular transport of membranes is largely mediated by the
microtubular network, and treatment of cellular extracts with taxol,
followed by pelleting of the resulting microtubules and associated
structures, allows the rapid isolation and characterization of a
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been well characterized, and contains microtubules to which are
tethered endosomes, exocytic and transcytotic vesicles, as well as
putative intra-Golgi transport vesicles [25–28]. We have previously
shown that NDPK is present in MT/Ves and that NDPK binds to the
membranes in this fraction, but not to the microtubules [28].
Furthermore, the binding of NDPK to intracellular membranes is
disrupted by high concentrations of nucleotides, with an order of
selectivity typical of NDPKs. The present work seeks to further
characterize the association of NDPK with the intracellular vesicles
isolated by microtubule stabilization. The results indicate that NDPK
is present in most of the membrane vesicles obtained in this
manner. Additionally, it is eluted from these membranes by
nucleotides not as a complex, but as a single protein, and this is a
reversible process: as nucleotide concentrations are reduced to
micromolar levels, NDPK re-binds to membranes. Thus, the levels of
nucleotides in the cell have a profound effect on the reversible
interaction of soluble NDPKs with membranes. Furthermore, the
nucleotide sensitivity of this process is a consequence of the
intrinsic properties of NDPK and can be replicated in a simple
system consisting of puriﬁed soluble NDPKs and chemically deﬁned
phospholipids. Taken together, our observations reveal a simple and
novel mechanism for the reversible targeting of soluble NDPKs to
the membranes of intracellular transport vesicles, and support the
hypothesis that NDPK may play a role in localized regeneration of
nucleotides such as CTP and GTP, that are essential for the
biosynthesis of phospholipids as well as intracellular trafﬁc.
2. Materials and methods
2.1. Materials
Nucleotides were from Roche (GTP, GTPγS, GMP-PNP) and Sigma-
Aldrich (ATP, ADP, GDPβS). Taxol was purchased from Tocris, Sigma-
Aldrich or LC Laboratories. SDS-PAGE gels (NuPage, 10 or 12%, run in
MOPS/SDS buffer) were from Invitrogen. PIP strips™ were from
Echelon Biosciences. Anti-nm23 H1/2/3, anti-Arf6, and anti-von
Hippel–Lindau protein were from Santa Cruz Biotechnology, anti-
NDPK (Ab-1) and anti-α-tubulin (Ab-2) from LabVision, anti-dynamin
from Calbiochem, antibodies to Rac1 were from Santa Cruz and
Upstate Biotechnology (clone 23A8). Polyclonal antibodies to NDPK C
(Anti-C), afﬁnity-puriﬁed antibodies to NDPK A depleted of antibodies
cross-reacting with NDPK B (Anti-A), and afﬁnity-puriﬁed polyclonal
antibodies to NDPK Bwere a generous gift of Dr. Ioan Lascu (Université
de Bordeaux, France). For speciﬁc detection of NDPK B, IgGs cross-
reacting with NDPK A were removed by chromatography on columns
of immobilized NDPK A [29]; the fraction obtained is designated here
as Anti-B. Other antibodies were from sources previously described
[28]. Secondary antibodies labeled with infrared dyes (IRDye 800®
anti-rabbit and anti-goat, IRDye700® anti-mouse) were from Rockland
Immunochemicals. Phospholipids (dioleolylphosphatidylcholine
(DOPC), dioleoylphosphatidylethanolamine (DOPE), dioleoylphospha-
tidylserine (DOPS), 1,2-dioleoyl-sn-glycerol-3-phosphate (DOPA), and
carboxyﬂuorescein-labeled dioleoylphosphatidylethanolamine) were
from Avanti Polar Lipids.
2.2. Methods
2.2.1. Cell culture
NIH-3T3 ﬁbroblasts were cultured in Dulbecco's modiﬁed Eagle's
medium supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, 1 mM sodium pyruvate, 100 U/l penicillin and 100 μg/ml
streptomycin at 37 °C in a humidiﬁed 5% CO2 atmosphere. For ATP
depletion experiments, cultures were transferred to low glucose
medium, and were either left untreated in controls, or exposed to
50 mM 2-deoxyglucose and 10 mM sodium azide for 1 h.2.2.2. Isolation of microtubule-associated vesicles and cytosol
Microtubule-associated vesicles (MT/Ves) were isolated as
described previously [28]. Brieﬂy, NIH-3T3 cells were homogenized
in MEPS (35 mM PIPES pH 7.1 with NaOH, 5 mM MgSO4, 5 mM EGTA,
200 mM sucrose, 1 mM DTT; the calculated free Mg2+ is 4.3 mM)
containing protease inhibitors (2 mM PMSF, 1 mM benzamidine, 2 μg/
ml leupeptin). A post-nuclear supernatant (S1) was centrifuged at
40,000 ×g for 20 min. The supernatant (S2; small vesicles and cytosol)
was incubated at 37 °C for 30 min with 20 μM taxol (and nucleotides
when indicated) to polymerize tubulin, and pelleted at 16,000 ×g for
30 min at 4 °C. The pellets were brought to the original volume with
MEPS, taxol was added to 20 μM and the samples were centrifuged at
16,000 ×g. After a second wash, the pellets were solubilized in SDS-
PAGE sample buffer and analyzed by SDS-PAGE and immunoblotting.
In some instances the pellets were incubated with nucleotides after
two washes, and then processed for analysis. Samples were immuno-
blotted in parallel with antibodies to α-tubulin (and Rab4 or LAMP1,
when appropriate) to make sure that treatments did not affect tubulin
polymerization or co-pelleting of membrane vesicles. Proteins were
detected by chemiluminescence and quantitated with Maxim DL 2.12
(Diffraction Limited) software, or with the LI-COR® Odyssey infrared
imaging system. Results shown are representative of 3–10 separate
experiments. Cytosol from NIH-3T3 cells was prepared by centrifuga-
tion of the S2 supernatant in a TLA 100.3 rotor at 335,000 ×g for 1 h at
4 °C.
2.2.3. Immunoﬂuorescence and confocal microscopy
A 10 μl aliquot of MT/Ves pellet suspended in MEPS was spread
onto polylysine-coated coverslips and allowed to adhere for 3 min.
The specimen was ﬁxed with 4% paraformaldehyde for 10 min,
washed three times with PBS, incubated with NaBH4 to quench free
aldehyde groups and processed for indirect immunoﬂuorescence as in
[28], using an antibody to NDPK (Ab-1; 1:50), followed by Texas Red
anti-rabbit (1:100). Confocal and differential interference contrast
(DIC) images were acquired with an Olympus FluoView 300 confocal
laser scanning microscope (Olympus, Center Valley, PA).
2.2.4. Puriﬁcation of NDPK from human erythrocytes
Soluble NDPK was puriﬁed from human erythrocytes using a
modiﬁcation of an earlier protocol [30]. Brieﬂy, red blood cells were
lysed in buffer A (25 mM MOPS, 1 mM EDTA, 1 mM PMSF, pH 7.5) on
ice, and centrifuged at 17,600 ×g for 1 h. The supernatant was removed
and fractionated with 45%–85% ammonium sulfate. The 85% pre-
cipitate was suspended in buffer B (20 mM Tris, 1 mM EDTA, pH 8.0),
dialyzed to the same buffer, concentrated on an Amicon XM50
membrane, centrifuged for 15 min at 48,000 ×g, and applied to a
Reactive Yellow 3 column. Wash and elution with ATP were as
described [30], and yielded a mix of NDPKs A and B estimated to be
88% pure by SDS-PAGE, with a speciﬁc activity of 1200 U/mg when
tested by the coupled assay with 1 mM ATP and 0.2 mM TDP as
substrates [30]. The puriﬁed preparation (eNDPK)was stored at −20 °C
in PBS/50% glycerol.
2.2.5. Bacterial expression and puriﬁcation of human NDPK A
Wild-type NDPK A was expressed in E. coli from a pET 21b vector
generously provided by Dr. Marie-Lise Lacombe (INSERM U 402, Paris,
France), as described [31]. Puriﬁcation was by sequential chromato-
graphy in Q-Sepharose and Blue Sepharose as described by Lascu et al.
[32]. After concentration and desalting the preparation was stored in
liquid nitrogen. The puriﬁed protein (rNDPK A) was electrophoreti-
cally homogeneous and had a speciﬁc activity of 1600 U/mg.
2.2.6. Size exclusion chromatography
MT/Ves pellets were isolated, and incubated as described above in
MEPS buffer with 20 μM taxol, with or without 1 mM GTP. After
centrifugation at 16,000 ×g the supernatant was removed and applied
Fig. 1. NDPK-B is the major protein dissociated frommembranes by GTP, and behaves as
a hexamer, without associated proteins. (A) MT/Ves pellets were washed twice with
MEPS (containing protease inhibitors and 20 μM taxol), and then incubated in the same
buffer in the absence (Ctr) or presence of 1 mM GTP. After centrifugation for 30 min at
4 °C the supernatants were processed for SDS-PAGE, resolved in a 12% NuPage gel and
stained with silver. (B) Immunoblot analysis of the control (C) and GTP extracts obtained
as above, as well as whole cell lysates (L) from NIH-3T3 cells, with antibodies speciﬁc to
NDPK-A (Anti-A), NDPK-B (Anti-B) and polyclonal antibodies to NDPK-C (Anti-C). (C)
GTP extracts were obtained as above and fractionated on Superose 12 as described in
Materials and methods. Fractions were assayed for NDPK activity. The elution positions
of standards are indicated by (in kDa): a, 158; b, 67; c, 35, and d, 12.4. (D) Immunoblot of
column fractions from C with antibodies to NDPK B (Anti-B). Results shown are
representative of 5 independent experiments.
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with MEPS buffer at a ﬂow rate of 0.4 ml/min and fractions of 1.0 ml
were collected. The protein elution proﬁle was monitored at 280 nm,
and aliquots were assayed for NDPK activity. The samples were
precipitated with trichloroacetic acid, dissolved in sample buffer and
analyzed by SDS-PAGE followed by silver staining and/or immuno-
blotting. The column was calibrated with standards (IgG, BSA, β-
lactoglobulin, cytochrome C and vitamin B12) according to the
manufacturer's instructions. In earlier experiments we utilized a
Sepharose 6 HR 10/30 column with similar results.
2.2.7. Lipid overlay assay
Nitrocellulose membranes pre-spotted with phospholipids (PIP
strips™) were blocked for 1 h at 25 °C with 3% fatty-acid free bovine
serum albumin in Tris-buffered saline with 0.1% Tween-20 (TBST).
Blots were overlaid with 4 ml of 3.75 μg/ml puriﬁed rNDPK A in
blocking solution, with or without 1 mM GTP, for 1 h at 4 °C. The
membranes were washed 6 times for 5 min with TBST, and then
incubatedwith primary antibody against NDPK for 1 h. After 4washes,
the blot was incubated with secondary antibody, washed 4 more
times, and developed using enhanced chemiluminescence. The same
procedure was followed with cytosol from NIH-3T3 cells.
2.2.8. Liposome binding assays
The lipid combinations used were (in molar ratios): DOPC:DOPS,
DOPC:DOPE and DOPC:DOPA (80:20), and DOPC:DOPE:DOPS, DOPC:
DOPE:DOPA (60:20:20). Small unilamellar vesicles were prepared by
mixing the appropriate combination of lipid stock solutions in
chloroform in a glass tube. The solvent was evaporated under a
stream of nitrogen and the samples were further dried in a SpeedVac
for 1 h. Lipids (1.8 μmol) were incubated for 1 h at room temperature
in 90 μl of MEPS buffer with 400 mM sucrose, resuspended in a vortex
mixer and sonicated on ice in a bath sonicator (Model G112SPIT,
Laboratory Supply Company, Hicksville, NY) for 8–12 min. Prior to
experiments, cytosol or puriﬁed proteins were diluted in MEPS with
100 mM sucrose and centrifuged in a Beckman Airfuge at 167,000 ×g
for 10 min to remove any aggregates. Cytosol (1.5–1.8 mg/ml) or
puriﬁed NDPK (0.8–5 μM)were incubated with liposomes (0.4 mg/ml)
at 30 °C for 30 min. After centrifugation at 200,000 ×g for 30 min at
25 °C in a TLA 120.1 rotor, the supernatants were removed and the
pelletswere resuspended inMEPSbufferwithorwithout1mMGTP. The
samples were incubated for 30 min at 30 °C and pelleted as above. The
supernatants and pellets were resolved by SDS-PAGE and immuno-
blotted. Lipid recovery was uniform, as established using carboxyﬂuor-
escein-labeled phosphatidylethanolamine (0.2 mol%) as a marker. All
results shown are representative of 3–6 separate experiments.
3. Results
We have previously shown that nucleoside diphosphate kinase
(NDPK) co-puriﬁes with intracellular vesicles associated with taxol-
stabilized microtubules (MT/Ves), but dissociates from this fraction
upon incubation with 1 mM GTP or ATP [28]. Guanine nucleotide
analogs also elute NDPK from membranes: at 1 mM, GTPγS and
GDPβS are as effective as GTP, whereas GMP-PNP only induces a
partial release. This order of efﬁcacy is not the one expected from the
binding site of GTP-binding proteins, where GTPγS and GMP-PNP act
alike, and have opposite effects to those of GDPβS. Rather, it parallels
the rank order of afﬁnity of these compounds for NDPK, leading to the
suggestion that the nucleotide binding site involved in the dissocia-
tion process is that of NDPK [28]. The simplest interpretation of this
behavior is that binding of nucleotides to the active site triggers the
dissociation of NDPK from its binding site in the vesicles. On the other
hand, nucleotides often disrupt interactions between microtubules,
motors and their membrane cargo [33–35]. We found that dynein and
kinesin, as well as Rab4 and Lamp1, remained in the pellet aftertreatment with 1 mM GTP or ATP [28], suggesting that the association
of motors plus early and late endosomal membranes with micro-
tubules was intact. However, the elution of NDPK by nucleotides could
be linked to the release of yet another component of the fraction.
3.1. NDPK is the main protein released from membranes by GTP
To determine whether 1 mM GTP dissociated other components
concomitantly with NDPK, we washed MT/Ves pellets in MEPS
buffer with or without 1 mM GTP, centrifuged the samples and
examined the protein composition of the supernatants by SDS-PAGE
followed by silver staining and immunoblotting. A prominent band
migrating at the position expected for NDPK (∼18 kDa) is present in
the GTP extract, but not in the control (Fig. 1A, arrow). Aside from
Fig. 2. The interaction of NDPK with membranes is controlled by its substrates, and is
abolished by ATP depletion. (A) Nucleotides were present during taxol-induced
polymerization of microtubules at the concentrations indicated. The amounts of
NDPK in the resultingMT/Ves pellets were assessed as inMaterials andmethods. Values
shown are ratios of the amounts of NDPK in nucleotide-treated samples to those
measured in controls run in parallel with no added nucleotides, expressed as percent of
control. n=2–3 for GTPγS and GDPβS, and 3–9 for ATP, GTP and ADP. Error bars indicate
S.E. of means. (B) Cells were kept in low glucose medium (4 samples) or treated with
deoxyglucose and azide (D/A; 2 samples) as in Materials and methods. Following
polymerization with taxol and centrifugation, supernatants (Ctr SN, D/A SN) were
removed and pellets were washed twice. Three Ctr samples were extracted with 1 mM
GTP and pelleted (GTP pellet). Pellets were then resuspended as follows: one each of Ctr,
D/A, and GTP pellets in MEPS buffer (−), one each of D/A and GTP pellets in Ctr SN, and
one GTP pellet in D/A SN. After 30 min on ice, samples were centrifuged and the pellets
were analyzed by SDS-PAGE followed by immunoblotting with antibodies to NDPK B
(Anti-B). Results are representative of 3 experiments.
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essentially the same. Immunoblotting with antibodies to NDPKs A, B
and C indicated that this band consists mostly of NDPK B (Fig. 1B),
which is expressed at higher levels in murine tissues than other
isoforms [16], as well as trace amounts of NDPK A. NDPK C is
detectable only in the cell lysate.
3.2. NDPK is released as an active hexamer, without associated proteins
To conﬁrm the identity of this protein as NDPK, the supernatants
obtained in the presence of GTP were further analyzed by size-
exclusion chromatography, and the NDPK content of individual
fractions was measured using enzyme activity assays, SDS-PAGE and
immunoblotting. As seen in Fig. 1C, the GTP extract contains NDPK
activity that elutes in one peak centered at approximately 100 kDa, the
size expected for a hexamer of 18 kDa subunits. The enzyme activity
overlapswith a band identiﬁable asNDPKby immunoblotting (Fig.1D).
A similar analysis of control extracts shows no NDPK activity above
basal levels and no reactivity with antibodies to NDPK in immuno-
blots (not shown). These experiments verify that the 18 kDa band
seen in Fig. 1A is NDPK, and show that GTP releases enzymatically
active NDPK, in its native, hexameric state. Moreover, the apparent
molecular mass of 100 kDa demonstrates that NDPK is released
alone, and not in a complex with other proteins.We also performed immunoblot analyses of theMT/Ves pellet with
antibodies against known NDPK binding partners, such as Arf6,
dynamin, Rac1, and the von Hippel–Lindau protein. Only Rac1 and
Arf6 were detected in the MT/Ves pellet, and neither was released
upon nucleotide treatment (not shown). In addition, although [α-32P]-
GTP overlay assays of the MT/Ves fraction revealed the presence of
several small GTP binding proteins, none were released by GTP
treatment (not shown).
3.3. The binding of NDPK to intracellular vesicles is controlled by its
catalytic cycle
GTP, ATP and the thiophosphate analogs GTPγS and GDPβS, which
bind tightly to NDPKs [5] release similar amounts of NDPK from the
MT/Ves fraction, whereas GMP-PNP, which binds with low afﬁnity to
NDPK, is far less effective [28]. This suggests that the nucleotide effects
on the association of NDPK to membranes are intimately linked to its
catalytic properties. To address this issue in depth, we determined the
dose–response relationships for release of NDPK from the MT/Ves
fraction by GTP, ATP, ADP, GTPγS and GDPβS.
As the concentration of GTP or ATP increases from 1 μM to 1 mM,
the amounts of NDPK bound to the MT/Ves pellet in the presence of
GTP or ATP decreases markedly (Fig. 2A). GTPγS and GDPβS inhibit
binding in a dose-dependent manner and with signiﬁcantly higher
potency than ATP or GTP. In contrast, ADP decreases the amount of
NDPK bound by 70–80% at all concentrations tested.
While the results obtained at high concentrations of nucleotides
conﬁrm our previous data on the dissociation of NDPK from
membranes, examination of the effects of low concentrations of
these compounds offers a new insight into the association process.
Unexpectedly, the lowest concentration of GTP and ATP, 1 μM,
consistently raised the amount of NDPK associated with MT/Ves to
120–125% of the control value. This increase is not observed with the
GTP analog GTPγS which binds to NDPK with relatively high afﬁnity,
but is a poor substrate for phosphate transfer [5], and suggests that
only nucleotides that transfer phosphate to NDPK can promote the
association of NDPK with membranes. If so, reducing the concentra-
tion of E∼P should promote dissociation. Indeed, ADP, which is an
acceptor for the phosphate of E∼P and thus dephosphorylates the
enzyme, induces dissociation even at 1 μM. In contrast, at 1 μM,
GDPβS, which is a poor phosphate acceptor, has little or no effect on
the association of NDPK with membranes. Collectively, these data
indicate that the association of NDPK with intracellular vesicles is a
reversible process whose dynamics are controlled by the relative
amounts of the phosphorylated intermediate, E∼P, and the free
enzyme, E.
If this reasoning is correct, a reduction in the [NTP]/[NDP] ratio in
cells, which necessarily decreases the [E∼P]/[E] ratio, should decrease
signiﬁcantly the amounts of NDPK bound to MT/Ves. To test this
hypothesis, we assessed the levels of NDPK in MT/Ves fractions
isolated from cells pre-incubated with the glycolysis inhibitor 2-
deoxyglucose and the mitochondrial poison sodium azide (D/A), a
treatment that markedly depletes cytosolic ATP (and consequently
other NTPs), and reduces markedly the [ATP]/[ADP] ratio, as well as
the levels of free ATP and GTP [36]. Fig. 2B shows that MT/Ves pellets
prepared from cells pre-treated with D/A contain only traces of NDPK
(7±5% of control, n=4), as would be expected if the association of
NDPK to MT/Ves depended on the levels of ATP. There is, however, the
possibility that the decrease in binding is due to a secondary effect of
the D/A treatment, which could decrease the number of NDPK binding
sites on the MT/Ves fraction or induce a decline in the actual amounts
of cytosolic NDPK. To address this point, we performed several control
experiments: in one, we incubated MT/Ves pellets obtained from D/A-
treated cells with cytosol from the control cells, centrifuged the
preparation and measured NDPK in the pellet. This same procedure
was repeated using cytosol from D/A-treated cells, and from control
Fig. 3. NDPK localizes to most vesicular structures associated with microtubules. Samples were prepared as in Materials and methods; the antibody to NDPK was Ab-1. Left panel:
Confocal immunoﬂuorescence of MT/Ves pellets showing localization of NDPK (red) to many vesicular structures of varying sizes and shapes that are often distributed along linear
tracks. Right panel: the corresponding DIC image demonstrates that most of these vesicles are associated with the underlying microtubular network. Comparison of the two panels
reveals that nearly all the vesicles seen in the DIC image contain NDPK.
Fig. 4. rNDPK A binds to immobilized phospholipids in a GTP-sensitive manner. PIP
strips™ were incubated with puriﬁed rNDPK A as described in Materials and methods,
in the presence and absence of 1 mM GTP, and the bound protein was detected with
antibodies to NDPK A (Anti-A). The location of each lipid is shown in the diagram on the
right. Abbreviations are: S1P, sphingosine-1-phosphate; LPA, lysophosphatidic acid;
PtdIns(3,4)P2, phosphatidylinositol (3,4) bisphosphate; LPC, lysophosphocholine;
PtdIns(3,5)P2, phosphatidylinositol (3,5) bisphosphate; PtdIns, phosphatidylinositol;
PtdIns(4,5)P2, phosphatidylinositol (4,5) bisphosphate; PtdIns(3)P, phosphatidylinositol
(3) phosphate; PtdIns(3,4,5)P3, phosphatidylinositol (3,4,5) trisphosphate; PtdIns(4)P,
phosphatidylinositol (4) phosphate; PA, phosphatidic acid; PtdIns(5)P, phosphatidyli-
nositol (5) phosphate; PS, phosphatidylserine; PE, phosphatidylethanolamine; PC,
phosphatidylcholine.
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stripped of NDPK with 1 mM GTP and therefore contain signiﬁcant
amounts of residual GTP. The results in Fig. 2B show that in all cases
NDPK re-bound to the MT/Ves fraction. This set of experiments
indicates that both MT/Ves membranes and cytosolic NDPK from D/A-
treated cells retain their ability to associate, as long as the NTP
concentration in the incubation mixture is at a minimum level.
Therefore, the lower binding of NDPK to MT/Ves isolated from cells
treated with D/A is likely to be the consequence of a lowered [ATP]/
[ADP] ratio.
3.4. NDPK localizes to the majority of vesicular structures associated
with MT
Our previous biochemical data indicate that in the MT/Ves
fraction NDPK is not associated directly with microtubules [28],
given that when the polymerization of tubulin with taxol was
performed after membranes have been removed by centrifugation at
230,000 ×g, NDPK was absent from the microtubular pellet [28].
This lack of direct interaction between NDPK and microtubules is in
agreement with observations by others [37,38]. Analysis of the
taxol-stabilized MT/Ves fraction by confocal immunoﬂuorescence
and DIC conﬁrms this idea. MT/Ves pellets isolated from NIH-3T3
cells were placed on polylysine-coated coverslips, and processed for
indirect immunoﬂuorescence using an antibody to NDPK. As shown
in Fig. 3, NDPK localizes to numerous structures of varied size and
shape, most of them organized in linear arrays along the micro-
tubules that are clearly visible in the corresponding DIC image.
Similar DIC images have been obtained with microtubules poly-
merized with taxol from puriﬁed tubulin [39,40]. The heterogeneity
of the vesicles and their irregular distribution along the micro-
tubules is typical of similar fractions obtained from hepatocytes
[25,26] and 3T3-L1 adipocytes [27] by the same protocol utilized
here. Thus, transmission electron microscopy of this fraction has
revealed microtubules with many vesicles of variable size and
appearance attached along their lengths [25,26]. Inspection of Fig. 3
also demonstrates that NDPK localizes to nearly all of the vesicular
structures visible in the DIC image. The widespread distribution of
NDPK seen in experiments like the one in Fig. 3 suggests that it
binds to a universal component of intracellular membranes, namely
lipids. This would agree with recent results showing that NDPKs A
and B bind to acidic phospholipids [19, 24]. Thus, our next step was
to determine whether nucleotides affect the direct association of
NDPK with lipids.3.5. NDPK binds to phospholipids in a nucleotide sensitive manner
In preliminary tests we used a protein lipid overlay assay.
Membrane strips pre-spotted with different phospholipids were
incubated with cytosol from NIH-3T3 cells, as well as puriﬁed
NDPKs, and then probed with antibodies against NDPK. Fig. 4
illustrates the results obtained with rNDPK A, in the presence and
absence of GTP. The enzyme displays a preference for PtdIns(5)P,
PtdIns(3)P, PtdIns(4)P, PtdIns and PS. When GTP is added, the binding
of rNDPK A to all these phospholipids is decreased, but the extent of
the GTP-induced reduction varies from 66% (PS) to 35% (PtdIns(3)P) of
the control value. The enzyme from cytosol also binds to PS and
phosphoinositides, albeit with a slightly distinct selectivity (not
shown). There was no detectable binding of murine or human NDPK
to immobilized PC, PE, sphingosine phosphate or lysophospholipids.
Although this type of assay does not necessarily reﬂect binding afﬁnity
or speciﬁcity in solution, and sometimes fails to detect all the
phospholipids to which a protein actually binds [41], it is clear from
Fig. 5. Interaction of NDPK from cytosol and puriﬁed eNDPK with liposomes of deﬁned
composition. Liposomes were incubated with cytosol from NIH-3T3 cells (upper panel)
or with puriﬁed eNDPK (lower panel) as described in Materials and methods,
centrifuged, and washed with buffer alone or buffer containing 1 mM GTP. The bound
protein was detected by SDS-PAGE and immunoblotting with Anti-nm23 H1/2/3.
Abbreviations are: PC: dioleylphosphatidylcholine, PE: dioleylphosphatidylethanola-
mine, PS: dioleylphosphatidylserine and PA: 1,2-dioleoyl-sn-glycero-3-phosphate. The
bar graph shows the average band intensity measured in 4 experiments, normalized to
protein. Error bars are S. E. of means.
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phospholipids, as reported by Tokarska-Schlattner et al. [24], and
does so in a GTP-sensitive manner.
We then examined how the nucleotide-sensitive binding of NDPK
to pure lipids translated into a more physiological experimental
system, that is, liposomes, using a sedimentation method [42]. Brieﬂy,
NDPK from cytosol was incubated with sucrose-loaded small
unilamellar vesicles of deﬁned phospholipid composition. The
samples were pelleted by ultracentrifugation and the level of NDPK
bound to the liposomes was measured as in Materials and methods.
Fig. 5 shows that cytosolic NDPK from NIH-3T3 bound to liposomes of
different compositions, showing a preference for PA-containingmixes.Fig. 6. Scheme of NDPK-catalyzed phosphate transfer in the presence of phospholipids (Cle
complex; E∼P·N1DP: phosphorylated enzyme–product (nucleoside diphosphate1) comple
substrate (nucleoside diphosphate2) complex; E·N2TP: enzyme–substrate (nucleoside tripho
of NDP or NTP; E∼P·Lipid: proposed phosphorylated enzyme–phospholipid complex.There was negligible binding to liposomes made of pure PC (not
shown). This result is in agreement with the ﬁnding that puriﬁed
NDPK A and B prefer anionic to neutral phospholipids [19,24]. More
importantly, in the presence of 1 mM GTP (or ATP), the levels of
cytosolic NDPK associated with liposomes were noticeably reduced.
Similar results were obtained with puriﬁed eNDPK (Fig. 5, lower
panel) and rNDPK A (not shown): the puriﬁed proteins bound to
several combinations of phospholipids, and the bindingwas decreased
by 1 mM GTP or ATP. Note that the last step of the puriﬁcation
procedures for both rNDPK A and eNDPK involves elution of the
enzyme from a dye columnwith ATP; as a result, both preparations are
likely to be partially phosphorylated [43] and therefore able to
associate with liposomes in the absence of added NTP.
Taken together, these ﬁndings imply that the mechanism of
binding to the liposomes and to the MT/Ves isolated from cells is
essentially the same. Furthermore, the results shown in Figs. 4 and 5
(lower panel) demonstrate conclusively that the nucleotide-sensitive
binding of NDPK to intracellularmembranes can be reconstitutedwith
a minimal set of components, namely puriﬁed enzyme and lipids.
4. Discussion
Our results conﬁrm recent work [19,24] showing that soluble
NDPKs can associate with membranes by binding directly to lipids.
The interaction does not require additional proteins, although it is
conceivable that it might be strengthened by additional interactions
with other membrane components. Also, the data suggest that the
formwith highest afﬁnity for lipids is the phosphoenzyme. Therefore,
the equilibrium between membrane-bound and soluble NDPK will be
determined by the availability of the phosphorylated enzyme.
The equilibrium constant of reaction (a),
½E∼P½NDP⇌½E½NTP
lies in the range of 0.15 to 0.5 for NDPKs of various species (reviewed
in [44]). The concentration of ATP in vivo exceeds those of other NTPs,
so [NTP]/[NDP] is approximately equal to the [ATP]/[ADP] ratio, which
in most cells, including NIH-3T3 ﬁbroblasts [45], is around 10. Under
these conditions, the ratio [E∼P]/[E] is 1.5–5, allowing the binding of
NDPK to membranes.
Because of the ping-pong mechanism of NDPK (Fig. 6), NDPs not
only dephosphorylate E∼P, but also bind to the free enzyme, E, acting
as dead end inhibitors [3]. In either case, if E∼P is the form that
associates with membranes, NDPs, in this case ADP, should inhibit
binding at all concentrations, either by removing free enzyme
available for phosphorylation, or by dephosphorylating E∼P, and this
is what is seen in Fig. 2.
NDPK's Km for ATP is 0.3 mM, one order of magnitude lower than
the Ki for dead end inhibition, 3 mM [3]. Thus, the binding of NTPs to
E∼P forming abortive complexes (E∼P∙NTP) (Fig. 6) is only observed atland notation). E: free enzyme; E·N1TP: enzyme–substrate (nucleoside triphosphate1)
x; E∼P: phosphorylated enzyme intermediate; E∼P·N2DP: phosphorylated enzyme–
sphate2) complex; E·NDP, E∼P·NTP: dead-end complexes formed at high concentrations
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amounts of NDPs. This explains the progressive reduction in the
amounts of NDPK associated with membranes as the concentration of
ATP (and GTP) is raised. The marked difference in the behavior of
phosphorylating (ATP, GTP) and non-phosphorylating (GTPγS)
nucleotides is a result of the balance between phosphorylation and
inhibition, which is signiﬁcant for the natural nucleotides, but is
heavily biased towards inhibition in the case of the thio-modiﬁed
nucleotide.
Two critical questions remain: where does the lipid bind, and how
is the catalytic cycle of NDPK coupled to the association and
dissociation from membranes? The 3D structures of hexameric
NDPK show a symmetrical arrangement that can be described as
two identical trimers superimposed horizontally, forming a disk with
a diameter of 70Å and a thickness of 50Å (reviewed in [46]). There is a
single nucleotide-binding site per subunit, and the top and bottom
surfaces of the disk contain three active sites each. The binding site lies
in a crevice lined with basic residues, between a loop and a hairpin
formed by helices αA and α2. Preliminary studies using in silico
docking indicate that this site might accomodate a phospholipid such
as PA. In this aspect NDPK is reminiscent of the phosphatidylethano-
lamine-binding protein (PEBP), a 23 kDa basic protein that binds
phospholipids as well as GTP [47]. Similarly to NDPK, in the crystal
structure of PEBP the ligand binding site lies in a narrow crevice near
the surface, proximal to a strip of basic residues. Like NDPK, the bovine
PEBP structure is not related to other nucleotide binding proteins, or
to known lipid-binding proteins. Notably, the loop connecting helices
αA and α2 contains the conserved basic residues K56 and R58, newly
identiﬁed as essential for the binding of NDPK B to acidic phospho-
lipids [19]. A previous, groundbreaking report by Epand et al. [48]
demonstrated novel properties of the mitochondrial NDPK isoform,
NDPK D (or NM23-H4), namely the ability to cross-link bilayers and
transfer lipids between them, provided that cardiolipin is present.
These observations were recently expanded by Tokarska-Schlattner et
al. [24], who demonstrated that NDPK-D binds strongly to other acidic
phospholipids as well, and that residue R90 (D57 in NDPKs A and B)
from the same loop is essential for the binding of NDPK-D to artiﬁcial
and native membranes. Additionally, results from Orlov et al. [21] are
consistent with an involvement of the αA-α2 hairpin in the
association process. Brieﬂy, a synthetic peptide with a sequence that
encompasses helix αA dissociates NDPK B from rod outer segment
membranes, whereas peptides homologous to other portions of the
protein have no effect.
There are no detectable differences between the 3D structures of
the phosphorylated NDPK and the free enzyme [49], but binding of
nucleotides to the active site results in a small conformational change,
where the αA-α2 hairpin moves 2Å and locks the nucleotide in place.
This suggests a mechanism by which the conformational change
associated with nucleotide binding could trigger dissociation of NDPK
from bilayers: in E∼P, the nucleotide binding site is in the “open”
conformation, allowing its binding to phospholipids, while occupation
of the site, followed or not by phosphate transfer to NDP, closes the
cleft and releases the enzyme from the lipid. Soluble NDPK is
eventually rephosphorylated by NTP, and is again capable of
associating with membrane lipids.
In conclusion, our present studies suggest that in vivo the high
[ATP]/[ADP] ratio promotes phosphorylation of NDPK and its associa-
tion with membranes, where it could transfer phosphate to locally
generated NDPs. Schneider et al. [50] suggested that because of its
high concentration in the cytosol and the expected prevalence of its
phosphorylated state at normal [ATP]/[ADP] ratios, soluble NDPKs
could serve as a cellular reservoir of high energy phosphate. Targeting
of such a reservoir to membranes may be relevant to the operation of
the pathways of phospholipid synthesis, which require CTP (reviewed
in [51]), as well as the multiple GTPases that control intracellular
membrane transport.Acknowledgements
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